Editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.

Company: Seegene Incorporated

Bloomberg ticker: 096530 KS

Market cap: US$5,924m

Background: Seegene Incorporated is a Korean company developing, manufacturing and distributing molecular diagnostic reagents. Seegene mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases (STD) pathogens, human papillomavirus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products.

World Class Benchmarking of Seegene

(Click on image to enlarge)

• Profitable Growth rank of 1 was same compared to the prior period’s 1st rank
• This is World Class performance compared to 410 medium Health Care companies worldwide
• Profitability rank of 1 was the same as its Growth rank of 1
• Profitability rank of 1 was up compared to the prior period’s 2nd rank
• This is World Class performance compared to peers
• Growth rank of 1 was the same compared to the prior period’s 1st rank
• This is World Class performance compared to peers